Skip to main content


Log in

Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes: a case-series study

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript


We enrolled nine consecutive patients affected by newly diagnosed polymyalgia rheumatica and decompensated diabetes mellitus. All patients were treated with etanercept (25 mg twice weekly) and prednisone and were followed up to 1 year. At the sixth-month follow-up, etanercept and prednisone were withdrawn. Patients were seen at regular intervals (days 0, 30, 60, 90, 150, 180) and the following variables determined: erythrocytes sedimentation rate, C-reactive protein, fasting serum glucose, pain measured by visual analog scale, and the Health Assessment Questionnaire. Our results indicate that etanercept might have some steroid-sparing effects, but controlled investigations are needed to support etanercept use in clinical practice for this kind of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others


  1. Cimmino MA, Zaccaria A (2000) Epidemiology of polymyalgia rheumatica. Clin Exp Rheumatol 18(suppl 20):S9–S11

    PubMed  CAS  Google Scholar 

  2. Salvarani C, Macchioni P, Bioardi L (1997) Polymyalgia rheumatica. Lancet 350:43–47

    Article  PubMed  CAS  Google Scholar 

  3. Kyle V (1997) Polymyalgia reumatica. Prescribers’ J 3:138–144

    Google Scholar 

  4. Chuang T, Hunder GG, Ilstrup DM, Kurland LT (1982) Polymyalgia rheumatica—a 10 year epidemiological and clinical study. Ann Intern Med 97:672–680

    PubMed  CAS  Google Scholar 

  5. Cimmino MA, Moggiana G, Montecucco C, Caporali R, Accardo S (1994) Long term treatment of polymyalgia rheumatica with deflazacort. Ann Rheum Dis 53:331–333

    Article  PubMed  CAS  Google Scholar 

  6. Gran JT (1999) Current therapy of polymyalgia rheumatica [editorial]. Scand J Rheumatol 28:269–272

    Article  PubMed  CAS  Google Scholar 

  7. Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347:261–271

    Article  PubMed  Google Scholar 

  8. Salvarani C, Boiardi L, Mantovani V, Ranzi A, Cantini F, Olivieri I et al (1999) HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity. Ann Rheum Dis 58:303–308

    Article  PubMed  CAS  Google Scholar 

  9. Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B (2001) Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 134:106–114

    PubMed  CAS  Google Scholar 

  10. Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J et al (2002) A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 46:1309–1318

    Article  PubMed  CAS  Google Scholar 

  11. Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C et al (2004) Prednisone plus methotrexate for polymyalgia rheumatica. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 141:493–500

    PubMed  CAS  Google Scholar 

  12. Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P et al (2007) Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med 46(9):631–639

    Google Scholar 

  13. The Oxford Centre for Evidence-based Medicine Levels of Evidence (2007) Accessed July 2 2007

  14. Kalke S, Mukerjee D, Dasgupta B (2000) A study of the health assessment questionnaire to evaluate functional status in polymyalgia rheumatica. Rheumatology 39(8):883–885

    Article  PubMed  CAS  Google Scholar 

  15. Salvarani C, Cantini F, Niccoli L, Catanoso MG, Macchioni P, Pulsatelli L et al (2003) Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study. J Rheumatol 30(4):760–763

    PubMed  Google Scholar 

  16. Migliore A, Massafra U, Carloni E, Padalino C, Martin Martin S, Lasaracina F et al (2005) TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report. Eur Rev Med Pharmacol Sci 9(6):373–378

    PubMed  CAS  Google Scholar 

  17. Tam LS, Tomlinson B, Chu TT, Li TK Li EK (2007) Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol 26(9):1495–1498

    Article  PubMed  Google Scholar 

  18. Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J (2006) Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 24(1):83–86

    PubMed  CAS  Google Scholar 

  19. Yazdani-Biuki B, Mueller T, Brezinschek HP, Hermann J, Graninger W, Wascher TC (2006) Relapse of diabetes after interruption of chronic administration of anti-tumor necrosis factor-alpha antibody infliximab: a case observation. Diabetes Care 29(7):1712–1713

    Article  PubMed  Google Scholar 

  20. Adachi T, Toishi T, Takashima E, Hara H (2006) Infliximab neutralizes the suppressive effect of TNF-alpha on expression of extracellular-superoxide dismutase in vitro. Biol Pharm Bull 29(10):2095–2098

    Article  PubMed  CAS  Google Scholar 

  21. Iyama S, Okamoto T, Sato T, Yamauchi N, Sato Y, Sasaki K et al (2001) Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer. Arthritis Rheum 44(9):2160–2167

    Article  PubMed  CAS  Google Scholar 

  22. Adachi T, Inoue M, Hara H, Maehata E, Suzuki S (2004) Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol 181(3):413–417

    Article  PubMed  CAS  Google Scholar 

  23. Bernstein LE, Berry J, Kim S, Canavan B, Grinspoon SK (2006) Effects of etanercept in patients with the metabolic syndrome. Arch Intern Med 166(8):902–908

    Article  PubMed  CAS  Google Scholar 

Download references


We thank Paola Martorana a lot for language revision of this manuscript.



Author information

Authors and Affiliations


Corresponding author

Correspondence to Salvatore Corrao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corrao, S., Pistone, G., Scaglione, R. et al. Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes: a case-series study. Clin Rheumatol 28, 89–92 (2009).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: